I don't get what is going on with this one, this week. I know biotechs are hurting and the market in general blah blah but ARQL has good news last weekend and docs are at a conference hearing about them for days. They are even touted as the next DNDN (maybe that's not a good thing! LOL).
With regards to SGXP - it was posted on yahoo board that a broker is aware of 10 term sheets for their PRE-CLINICAL program in one of the richest deals in biotech for a preclinical.
News 
Market Data 
Discover 
